ATP5MC3

ATP synthase membrane subunit c locus 3 P48201 AT5G3_HUMAN
Protein Coding Chr 2 2q31.1 Swiss-Prot reviewed Entrez 518
Mutations
184
CL 7 · Tissue 174
Samples
60
CL 3 · Tissue 56
Peptides
38
unique mutant peptides
Transcripts
3
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations1847174
Samples60356
Peptides38236

Function

ATP5MC3 · ATP synthase membrane subunit c locus 3

This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene is one of three genes that encode subunit c of the proton channel. Each of the three genes have distinct mitochondrial import sequences but encode the identical mature protein. Alternatively spliced transcript variants encoding different proteins have been identified. [provided by RefSeq, Jun 2010].

Isoforms & Proteins

3 transcripts · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000284727 P48201 62 38
ENST00000392541 P48201 61 38
ENST00000409194 P48201 61 38

Gene Properties

Type
Protein Coding
Chromosome
2
Cytoband
2q31.1
Entrez ID
Aliases
ATP5G3DYTSPGP3

Recurrent Mutations

All 38 amino-acid changes on canonical ENST00000284727 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in ATP5MC3 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in ATP5MC3 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Hodgkins Lymphoma
0/16 0%
2/122 2%
Esophageal Squamous Cell Carcinoma
0/51 0%
16/2550 1%
Burkitts Lymphoma
0/32 0%
1/196 1%
Endometrial Carcinoma
0/42 0%
2/612 0%
Other Solid Cancers
0/94 0%
4/1515 0%
Cervical Carcinoma
0/35 0%
1/422 0%
Gastric Carcinoma
0/74 0%
4/1809 0%
Colorectal Carcinoma
2/143 1%
4/3239 0%
Ovarian Carcinoma
0/109 0%
2/998 0%
Glioma
0/52 0%
4/2127 0%
Neuroendocrine Tumour
0/154 0%
1/577 0%
Hepatocellular Carcinoma
1/46 2%
2/2210 0%
Small Cell Lung Carcinoma
0/9 0%
1/752 0%
Other Sarcomas
0/69 0%
1/699 0%
Squamous Cell Lung Carcinoma
0/57 0%
1/810 0%
Head and Neck Carcinoma
0/85 0%
2/1574 0%
Biliary Tract Carcinoma
0/54 0%
1/950 0%
B-Lymphoblastic Leukemia
0/55 0%
2/2640 0%
Non-Small Cell Lung Carcinoma
0/304 0%
1/1390 0%
Pancreatic Carcinoma
0/89 0%
1/1611 0%
Prostate Carcinoma
0/13 0%
1/2105 0%
Kidney Carcinoma
0/85 0%
1/1862 0%
B-Cell Non-Hodgkins Lymphoma
0/88 0%
1/2534 0%
Breast Carcinoma
0/144 0%
1/3264 0%

Mutation Distribution

Where ATP5MC3 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in ATP5MC3 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

Mutations

All 184 mutations in ATP5MC3

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide